Skip to main content
. 2017 Sep 8;29(1):e1. doi: 10.3802/jgo.2018.29.e1

Table 2. Recurrence and mortality in IREC.

Characteristics Lymphadenectomy (n=178) No lymphadenectomy (n=178) p-value
Recurrence 31 (17.4) 24 (13.5) 0.293
Site of recurrence 0.306
Pelvis 7 (3.9) 10 (5.6)
Nodes* 6 (3.4) 3 (1.7)
Spread 18 (10.1) 11 (6.2)
Decrease 23 (12.9) 33 (18.5) 0.145
Cause of decrease 0.028
Dead for tumor 15 (8.4) 10 (5.6)
Dead for other causes 6 (3.4) 20 (11.2)
Cause unknown 2 (1.1) 3 (1.7)

Data are shown as cases (%).

IREC, intermediate-risk endometrial cancer.

*Recurrence in nodes as first localization. Recurrence in 2 or more sites, or distant metastases.